| Preferred Name |
tocilizumab |
| Synonyms |
monoclonal antibody, MRA |
| ID |
http://purl.bioontology.org/ontology/MESH/C502936 |
| altLabel |
monoclonal antibody, MRA atlizumab MSB-11456 RO-4877533 BAT1806 RHPM-1 MSB11456 R-1569 BAT-1806 Roactemra RG-1569 Actemra |
| cui |
C5227772 C5226663 C5564824 C5227770 C2740854 C3272237 C2830231 C1609165 |
| HM |
D061067 |
| Inverse of RB |
0 I031V2H011 |
| LT |
TRD |
| Mapped to | |
| MDA |
20050818 |
| MeSH Frequency |
3145 |
| MMR |
20220214 |
| notation |
C502936 |
| PI |
*ANTIBODIES, MONOCLONAL (2005-2011) |
| prefLabel |
tocilizumab |
| SC |
1 |
| Scope Statement |
a humanised anti-interleukin-6 receptor monoclonal antibody |
| SRC |
Nippon Rinsho 2005 May;63 Suppl 5:723-7 |
| TERMUI |
T000967527 T549198 T001116066 T648929 T575947 T000967534 T000967531 T000967526 T794499 T000967532 T000967533 T001116065 T001092459 |
| TH |
NLM (2004) FDA SRS (2017) USAN (19XX) NLM (2003) NLM (2022) NLM (2012) NLM (2005) INN (19XX) NLM (2020) |
| tui |
T116 T129 T121 |